NO314846B1 - Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem - Google Patents
Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem Download PDFInfo
- Publication number
- NO314846B1 NO314846B1 NO19975365A NO975365A NO314846B1 NO 314846 B1 NO314846 B1 NO 314846B1 NO 19975365 A NO19975365 A NO 19975365A NO 975365 A NO975365 A NO 975365A NO 314846 B1 NO314846 B1 NO 314846B1
- Authority
- NO
- Norway
- Prior art keywords
- benzopyran
- dimethyl
- dihydro
- hydroxy
- sulfonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9510477.4A GB9510477D0 (en) | 1995-05-24 | 1995-05-24 | Organic compounds |
| PCT/EP1996/002257 WO1996037490A1 (en) | 1995-05-24 | 1996-05-24 | Benzopyrans and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO975365D0 NO975365D0 (no) | 1997-11-21 |
| NO975365L NO975365L (no) | 1998-01-15 |
| NO314846B1 true NO314846B1 (no) | 2003-06-02 |
Family
ID=10774940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19975365A NO314846B1 (no) | 1995-05-24 | 1997-11-21 | Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5905156A (enExample) |
| EP (1) | EP0828733B1 (enExample) |
| JP (1) | JPH11505820A (enExample) |
| KR (1) | KR100437981B1 (enExample) |
| CN (1) | CN1077888C (enExample) |
| AR (1) | AR004489A1 (enExample) |
| AT (1) | ATE205204T1 (enExample) |
| AU (1) | AU703276B2 (enExample) |
| BR (1) | BR9609048A (enExample) |
| CA (1) | CA2217821C (enExample) |
| CO (1) | CO4700520A1 (enExample) |
| CZ (1) | CZ294474B6 (enExample) |
| DE (1) | DE69615019T2 (enExample) |
| DK (1) | DK0828733T3 (enExample) |
| ES (1) | ES2163634T3 (enExample) |
| FI (1) | FI973992L (enExample) |
| GB (1) | GB9510477D0 (enExample) |
| HU (1) | HU222772B1 (enExample) |
| IL (1) | IL118382A (enExample) |
| MY (1) | MY114924A (enExample) |
| NO (1) | NO314846B1 (enExample) |
| NZ (1) | NZ309765A (enExample) |
| PL (1) | PL184144B1 (enExample) |
| PT (1) | PT828733E (enExample) |
| RU (1) | RU2160735C2 (enExample) |
| SK (1) | SK283215B6 (enExample) |
| TR (1) | TR199701417T1 (enExample) |
| TW (1) | TW421646B (enExample) |
| WO (1) | WO1996037490A1 (enExample) |
| ZA (1) | ZA964209B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972894A (en) * | 1997-08-07 | 1999-10-26 | Cytran, Inc. | Peptides having potassium channel opener activity |
| GB9822024D0 (en) * | 1998-10-09 | 1998-12-02 | Novartis Ag | Organic compounds |
| GB9909792D0 (en) | 1998-12-04 | 1999-06-23 | Cambridge Bioclinical Limited | Potassium channel activators and their use |
| US6384244B2 (en) | 2000-05-18 | 2002-05-07 | Merck & Co., Inc. | Process for preparing cis- aminochromanols |
| ZA200501510B (en) * | 2002-08-29 | 2006-10-25 | Nissan Chemical Ind Ltd | Process for producing aminobenzopyran compound |
| US7098340B2 (en) * | 2003-05-14 | 2006-08-29 | Warner Lambert Company Llc | Benzyl sulfonamide derivatives |
| KR100704009B1 (ko) * | 2005-08-30 | 2007-04-04 | 한국화학연구원 | 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체 |
| BR112018006189A2 (pt) | 2015-09-28 | 2018-10-09 | Genentech Inc | compostos da fórmula, composição farmacêutica, métodos de tratamento de uma doença, de diminuição do fluxo de íons e de tratamento de prurido em um mamífero, método para tratamento de dores em um mamífero e uso de um composto |
| CN106008288A (zh) * | 2016-06-15 | 2016-10-12 | 西北农林科技大学 | 一种苯磺酰胺类化合物及其用途 |
| JP2020511511A (ja) * | 2017-03-24 | 2020-04-16 | ジェネンテック， インコーポレイテッド | ナトリウムチャネル阻害剤としての４−ピペリジン−ｎ−（ピリミジン−４−イル）クロマン−７−スルホンアミド誘導体 |
| TW202003490A (zh) | 2018-05-22 | 2020-01-16 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4971982A (en) * | 1987-07-06 | 1990-11-20 | Hoffmann-La Roche Inc. | Benzopyran derivatives |
| ES2030627A6 (es) * | 1990-11-28 | 1992-11-01 | Uriach & Cia Sa J | Procedimiento para la obtencion de compuestos benzopiranicos. |
| GB9102803D0 (en) * | 1991-02-11 | 1991-03-27 | Ici Plc | Pyridine compounds |
| KR950009863B1 (ko) * | 1991-05-22 | 1995-08-29 | 재단법인한국화학연구소 | 벤조피란 유도체와 그의 제조방법 |
| TW244350B (enExample) * | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
| US5236935A (en) * | 1992-05-21 | 1993-08-17 | Korea Research Institute Of Chemical Technology | Benzopyran derivatives and processes for the preparation thereof |
-
1995
- 1995-05-24 GB GBGB9510477.4A patent/GB9510477D0/en active Pending
-
1996
- 1996-05-22 TW TW085106034A patent/TW421646B/zh not_active IP Right Cessation
- 1996-05-22 MY MYPI96001911A patent/MY114924A/en unknown
- 1996-05-22 IL IL11838296A patent/IL118382A/xx not_active IP Right Cessation
- 1996-05-23 CO CO96026387A patent/CO4700520A1/es unknown
- 1996-05-24 ES ES96917431T patent/ES2163634T3/es not_active Expired - Lifetime
- 1996-05-24 PL PL96324042A patent/PL184144B1/pl not_active IP Right Cessation
- 1996-05-24 CA CA002217821A patent/CA2217821C/en not_active Expired - Fee Related
- 1996-05-24 BR BR9609048A patent/BR9609048A/pt not_active IP Right Cessation
- 1996-05-24 FI FI973992A patent/FI973992L/fi unknown
- 1996-05-24 US US08/952,549 patent/US5905156A/en not_active Expired - Lifetime
- 1996-05-24 PT PT96917431T patent/PT828733E/pt unknown
- 1996-05-24 WO PCT/EP1996/002257 patent/WO1996037490A1/en not_active Ceased
- 1996-05-24 AR ARP960102708A patent/AR004489A1/es active IP Right Grant
- 1996-05-24 EP EP96917431A patent/EP0828733B1/en not_active Expired - Lifetime
- 1996-05-24 AU AU60008/96A patent/AU703276B2/en not_active Ceased
- 1996-05-24 CN CN96194146A patent/CN1077888C/zh not_active Expired - Fee Related
- 1996-05-24 RU RU97120993/04A patent/RU2160735C2/ru not_active IP Right Cessation
- 1996-05-24 NZ NZ309765A patent/NZ309765A/xx unknown
- 1996-05-24 JP JP8535402A patent/JPH11505820A/ja not_active Ceased
- 1996-05-24 AT AT96917431T patent/ATE205204T1/de active
- 1996-05-24 TR TR97/01417T patent/TR199701417T1/xx unknown
- 1996-05-24 DE DE69615019T patent/DE69615019T2/de not_active Expired - Lifetime
- 1996-05-24 HU HU9801751A patent/HU222772B1/hu not_active IP Right Cessation
- 1996-05-24 ZA ZA9604209A patent/ZA964209B/xx unknown
- 1996-05-24 SK SK1577-97A patent/SK283215B6/sk not_active IP Right Cessation
- 1996-05-24 CZ CZ19973688A patent/CZ294474B6/cs not_active IP Right Cessation
- 1996-05-24 KR KR1019970708400A patent/KR100437981B1/ko not_active Expired - Fee Related
- 1996-05-24 DK DK96917431T patent/DK0828733T3/da active
-
1997
- 1997-11-21 NO NO19975365A patent/NO314846B1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bergmann et al. | Synthesis and antihypertensive activity of 4-(1, 2-dihydro-2-oxo-1-pyridyl)-2H-1-benzopyrans and related compounds, new potassium channel activators | |
| CA1332944C (en) | Isoquinoline derivatives, their preparation and their use | |
| EP1760073A1 (en) | Sulfonamide compound | |
| NO314846B1 (no) | Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem | |
| PL167832B1 (pl) | S posób wytwarzania nowych pochodnych benzopiranu PL PL PL | |
| CN110997653A (zh) | 芳基杂环哌啶酮甲酰肽2受体和甲酰肽1受体激动剂 | |
| HUP0400362A2 (hu) | Antiaritmiás hatású helyettesített benzopiránszármazékok | |
| US5574049A (en) | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans | |
| WO1994012493A1 (en) | 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyr ans, their use as pharmaceuticals | |
| US7423059B2 (en) | Pharmaceutically active compounds and methods of use | |
| AU665040B2 (en) | 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives | |
| MXPA97009004A (en) | Benzopira | |
| NZ245321A (en) | Substituted 6-(pyridin-4-yl)-2h-1-benzopyran derivatives and pharmaceutical compositions thereof | |
| JP2583028B2 (ja) | ２，２−ジアルキル−および２，２−ジアルキル−３，４−ジヒドロ−３−ヒドロキシ−−２ｈ−１−ベンゾピラン類 | |
| RU2104277C1 (ru) | 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран | |
| CZ282091B6 (cs) | 2,2-Dialkyl-2H-1-benzopyrany a 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrany | |
| PL172371B1 (pl) | Sposób wytwarzania 2,2-diaikilo- i 2,2-dialkilo-3,4- dihydro-3-hydroksy-2H-1-benzopiranów PL | |
| HK1014137B (en) | Benzopyrans and pharmaceutical compositions containing them | |
| CZ426399A3 (cs) | Nové deriváty fencyklidinů, způsob jejich přípravy a farmaceutické kompozice s jejich obsahem |